Partnering
Contact
Contact Information
Join Us
EN
CN
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
Southeast Asia Business
News
Company News
Partner News
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Investor Communication
Home
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
News
Company News
Partner News
Investors
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Partnering
Contact
Contact Information
Join Us
EN
CN
Acticor Biotech
Acticor Biotech
Product
Related News
【Acticor Biotech-Product ACT017】Participation of Acticor Biotech in ESOC 2023, first European Forum for Stroke Research
2023-05-26
【Acticor Biotech-Product ACT017】Acticor Biotech receives European Medicines Agency (EMA) endorsement on key parameters of ACTISAVE, its pivotal Phase II/III study for registration in Stroke
2022-12-05
【Acticor Biotech-Product ACT017】World’s First Clinical Trial to Test New Drug Glenzocimab for Heart Attacks
2022-11-22
【Acticor Biotech-Product ACT017】Acticor Biotech announces the enrollment of the first US patient in its Phase 2/3 study ACTISAVE for the treatment of stroke
2022-09-26
